AstraZeneca secures orders for virus vaccine under testing

Drug maker AstraZeneca has secured the first agreements Thursday for 400 million doses of a COVID-19 vaccine that is being trialed
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news

Related Links:

In conclusion, our results suggest a previously unknown mechanism whereby the canonical NF-κB cascade and a mitochondrial fission pathway interdependently regulate endothelial inflammation. Lin28 as a Target for Nerve Regeneration https://www.fightaging.org/archives/2020/05/lin28-as-a-target-for-nerve-regeneration/ Researchers here show that the gene Lin28 regulates axon regrowth. In mice, raised levels of Lin28 produce greater regeneration of nerve injuries. Past research has investigated Lin28 from the standpoint of producing a more general improvement in regenerative capacity. It improves mitoch...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Director of Vaccine Education Center at Children's Hospital of Philadelphia Dr. Paul Offit tells CNN's John King what concerns him about achieving a vaccine for coronavirus.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Abstract COronaVIrus Disease 2019 (COVID-19) is an on-going pandemic attributed to a novel virus named SARS-CoV-2. Comparing the statistics of incidence and death rates between nations reveals that there is discrepancy amongst countries in these regards, even between countries that share borders. We herein present information from the literature indicating how cross-protection against COVID-19 conferred by the encephalitis vaccine could be the reason for lower fatality rate in the countries where immunization against encephalitis is widespread or included in national programs. This may pave the way for arriving at...
Source: Accident and Emergency Nursing - Category: Emergency Medicine Authors: Tags: Arch Acad Emerg Med Source Type: research
First indications of the effectiveness of a potential vaccine against coronavirus may be available in the autumn, the head of the GAVI vaccine alliance told a Swiss newspaper, forecasting a long road from there to broad availability.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Trials could be speeded up by using risky strategy of deliberately introducing the virusCoronavirus – latest updatesSee all our coronavirus coverageScientists have warned there could be major delays in producing a Covid-19 vaccine if currentUK infection rates remain low and lengthy waiting times are needed to show if candidate products are working. As a result, some researchers insist that ministers must now consider implementing radical alternative measures to speed up vaccine development.In particular, they argue that Britain should considerdeliberately infecting volunteers involved in vaccine-testing projects &nda...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Vaccines and immunisation Coronavirus outbreak Medical research Infectious diseases Microbiology Science Health Source Type: news
The Royal Society president says scientists must not be made scapegoats for policy failuresCoronavirus – latest updatesSee all our coronavirus coverageIn 1981, a virus that had jumped the species barrier some decades earlier to infect humans began to wreak havoc among the gay community in San Francisco and New York. A taskforce was set up to study the cause of this disease, and it took a few years to identify HIV as the definitive cause of Aids and its genome to be sequenced, and nearly 15 years before a cocktail of drugs meant that having an HIV infection was no longer a certain death sentence.Forty years later, the...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research Health policy Vaccines and immunisation Politics Science Infectious diseases Aids and HIV Source Type: news
The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Moderna Inc Gilead Sciences Inc Vaccination and Immunization Remdesivir (Drug) Biotechnology and Bioengineering Clinical Trials Stocks and Bonds Research your-feed-healthcare Source Type: news
Publication date: Available online 22 May 2020Source: The LancetAuthor(s): Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jing-Xin Li, Shi-Po Wu, Bu-Sen Wang, Zhao Wang, Lei Wang, Si-Yue Jia, Hu-Dachuan Jiang, Ling Wang, Tao Jiang, Yi Hu, Jin-Bo Gou, Sha-Bei Xu, Jun-Jie Xu, Xue-Wen Wang, Wei Wang
Source: The Lancet - Category: General Medicine Source Type: research
The University of Oxford's COVID-19 vaccine trial has only a 50% chance of success as the coronavirus seems to be fading rapidly in Britain, the professor co-leading the development of the vaccine told the Telegraph newspaper https://bit.ly/2LQTNos.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Dozens of researchers across the globe are racing against time to come out with a vaccine for coronavirus that has infected nearly five million people and killed over 3,30,000 globally.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: AstraZeneca | COVID-19 | Health | Vaccines | Wuhan Coronavirus